Veritas Genetics Inc - Medical Equipment - Deals and Alliances Profile

Summary

Veritas Genetics Inc (Veritas Genetics) is a genome sequencing company that offers genomics testing and sequencing products and services. The company delivers actionable genetic insights to individuals and their doctors based on their DNA to manage their disease risk and plan their family health. Its products include myGenome, myBRCA, myBRCA HiRisk, myPrenatal, mycarrier, and myNewborn. Veritas Genetics myBRCA HiRisk is a multi-gene test to screen for hereditary breast and ovarian cancer risk. The company works with scientists, physicians, advisors, and patient advocates to design and deliver genetic testing solutions. It also has its presence in Shanghai and Hangzhou, China. Veritas Genetics is headquartered in Danvers, Massachusetts, the US.

Veritas Genetics Inc - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Veritas Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Veritas Genetics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Veritas Genetics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Veritas Genetics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Veritas Genetics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Veritas Genetics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Veritas Genetics Raises USD1.7 Million in Venture Financing 10
Veritas Genetics Raises USD30 Million in Series B Financing 11
Veritas Genetics Raises USD10 Million in Series A Financing Round 12
Equity Offering 13
Veritas Genetics Raises USD9.6 Million in Financing 13
Acquisition 14
Veritas Genetics Acquires Curoverse 14
Veritas Genetics Inc - Key Competitors 15
Veritas Genetics Inc - Key Employees 16
Veritas Genetics Inc - Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
Mar 28, 2018: Veritas Genetics Collaborates with Dr. Steven Narod and Womens College Hospital to Launch The Screen Project - a Population-Based BRCA Screening Initiative across Canada 18
Corporate Communications 19
Jun 15, 2017: Veritas Genetics Welcomes Dr. Robert C. Green and Dr. Natasha Y. Frank to its Medical & Scientific Advisory Board 19
Feb 08, 2017: Globally Renowned Molecular Genetics Expert, Birgit Funke, PhD, Joins Veritas Genetics as Vice President of Clinical Affairs 20
Legal and Regulatory 21
Jun 01, 2018: Veritas Genetics China Passes CAP & CLIA Inspections for Next Generation Sequencing 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List Of Tables


Veritas Genetics Inc, Medical Equipment, Key Facts 2
Veritas Genetics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Veritas Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Veritas Genetics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Veritas Genetics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Veritas Genetics Inc, Deals By Market, 2012 to YTD 2018 8
Veritas Genetics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Veritas Genetics Raises USD1.7 Million in Venture Financing 10
Veritas Genetics Raises USD30 Million in Series B Financing 11
Veritas Genetics Raises USD10 Million in Series A Financing Round 12
Veritas Genetics Raises USD9.6 Million in Financing 13
Veritas Genetics Acquires Curoverse 14
Veritas Genetics Inc, Key Competitors 15
Veritas Genetics Inc, Key Employees 16
Veritas Genetics Inc, Other Locations 17
Veritas Genetics Inc, Subsidiaries 17

List Of Figures


Xinjiang Goldwind Science & Technology Co Ltd, Performance Chart (2013 - 2017) 31
Xinjiang Goldwind Science & Technology Co Ltd, Ratio Charts 33
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals By Year, 2012 to YTD 2018 34
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals by Type, 2012 to YTD 2018 35

Veritas Genetics Inc - Medical Equipment - Deals and Alliances Profile

Veritas Genetics Inc (Veritas Genetics) is a genome sequencing company that offers genomics testing and sequencing products and services. The company delivers actionable genetic insights to individuals and their doctors

USD 250 View Report

Bureau Veritas SA - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Bureau Veritas SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe Bureau Veritas SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description,

USD 350 View Report

Myriad Genetics Inc (MYGN) - Product Pipeline Analysis, 2019 Update

Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The companys product portfolio includes molecular

USD 750 View Report

Myriad Genetics Inc (MYGN) - Product Pipeline Analysis, 2018 Update

Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The companys product portfolio includes molecular

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available